|
吗吲哚治疗单纯性肥胖的观察 |
| |
pothalamic neurons. Brain Res Bull 1985,15:33-8.
3 Samanin R, Bendottic, Bernasconi S, et al. Role of brain monoamines in the anorectic activity of mazindol and amphetamine in the rat. Eur J Pharmacol 1977,43:117-24.
4 Shisaishi T. Mazinol effects on the salivary and gastric acid secretary mechanisms. Folia Pharmacol Japan. 1984,83:159-72.
5 Fujimoto K, Sakata T, Tsatoui K, et al. Changes in meal patten and endogenous chemical determinations of mazindol. Folia Pharmacol Japan. 1984,83:425-32.
6 Nagai K, Mori T, Ookuza M, et al. Pharmacological action of mazindol on behavious and metabolish. Folia Pharmacol Japan 1984,83:133-45.
7 Usami M, Seino Y, Nishi S, et al. Effect of mazindol on insult and glucagon secretion invent medical hypothalamic obese rat. Folia Pharmacol Japan. 1985,85:297-303.
8 Inous S, Tsuchiya M, Takamura Y. Effects of mazindol on food intake in ventromedical hypothalamic lesioueal rats and glucose absorption in rats. Iat J obese 1987,11:63-9.
9Inoue S, Egawa M, Satoh S, et al. Chinical and basic aspects of an anoreciant, mazindol, as an antiobesity agent in Japan. Am J clin Nutr 1992,55:199-202.
10 Babbini M, Montanaro N, Strocchi P, et al. Enhancement of amphetamine-induced stereotyped behavior by benzodiazepines.Eur J. Pharmacol, 1971,13:330-40.
上一页 [1] [2]
上一个医学论文： 拜糖平治疗2型糖尿病肾病氮质血症十八例
下一个医学论文： 甲亢治疗前后P波振幅测定的临床意义
|
|
|
|
|
|
|
您现在的位置： 绿色健康网 >> 医学论文 >> 内科论文 >> 正文